{"entity":{"id":"nct06425926","kind":"trial","name":"Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors","aka":[],"tldr":"A phase 1/2 trial of GIM-531 in melanoma, run by Georgiamune Inc, now recruiting.","summary":"Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT06425926 by Georgiamune Inc, with 117 participants planned, started 2024-05-09 and due to reach its primary completion in 2026-12. Interventions recorded: GIM-531 and Anti-PD-1 monoclonal antibody.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06425926","url":"https://clinicaltrials.gov/study/NCT06425926"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["melanoma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["georgiamune"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06425926","phase":"1/2","setting":"A Phase 1/2, Open-label, Multi-center Study of the Safety, Tolerability, and Efficacy of GIM-531 as a Single Agent and in Combination With Anti-PD-1 in Advanced Solid Tumors","sponsor":"Georgiamune Inc","participation":[{"nct":"NCT06425926","source":"https://clinicaltrials.gov/study/NCT06425926","fetchedAt":"2026-10-07T16:54:39.727Z","studySha256":"2fd099e115e47eabffb1bfbfe4c460ff3cf1b26598c242d6c44276a6e757bcc3","overallStatus":"RECRUITING","lastUpdatePosted":"2026-08-14","leadSponsor":"Georgiamune Inc","collaboratorCount":0,"minimumAge":"18 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":117,"enrolmentType":"ESTIMATED","siteCount":11,"recruitingSiteCount":11,"countries":["United States"]}],"started":"2024-05-09","startedType":"actual","enrolled":117,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06425926/","neighbours":{"cancer":[{"id":"melanoma","kind":"cancer","name":"Melanoma","route":"/cancers/melanoma/"}],"company":[{"id":"georgiamune","kind":"company","name":"Georgiamune","route":"/companies/georgiamune/"}]}}